维普期刊资源整合服务平台（V6.5）

264篇 您的检索式：作者名="Mehren M"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT显示文摘	Blanke CD Demetri GD yon Mehren M		0，，04：	3
2	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，：	2
3	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	2
4	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	DEMETRI GD VON MEHREN M BLANKE CD	2002	N Engl J Med2002，347，：	1
5	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，：	1
6	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G D Von Mehren M Blanke C D	2002	N Engl J Med2002，347，7：	1
7	Long-term re- sults from a randomized phase II trial of standard versus high- er-dose imatinib rnesylate for patients with unresectable or me- tastatic gastrointestinal stromal tumors expressing NIT显示文摘	Blanke CD Demetri GD yon Mehren M	2008	Clin Oncol2008，26，4：	1
8	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
9	New therapeutic strategies for soft tissue sarcomas显示文摘	von Mehren M	2003	Curr Treat Options Oncol2003，4，6：	1
10	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumor显示文摘	Demetri GD Von Mehren M Blanke CD	2002	N Engl Med2002，347，7：	1
11	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	1
12	NCCN Task Force report:update on the management of patients with gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Antonescu GR	2010	J Natl Compr Canc Netw2010，82，：	1
13	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G van Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
14	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD yon Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
15	efficacy and safety of imatinib mesylate mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blande CD	2002	N Eng J Med2002，347，7：	1
16	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD yon Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
17	Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene显示文摘	Blezinger P Wang J Gondo M Quezada A Mehrens D French M Singhai A Sullivan S Rolland A Ralston R Min W		0，，：	1
18	efficacy and safe- ty of imatinih mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD yon Mehren M Blande CD	2002	N Eng J Med2002，347，7：	1
19	Long-term re- suits from a randomized phase Ⅱ trial of standard-versus high- er-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT 显示文摘	Blanke CD Demetri GD von Mehren M	2008	J Clin Oncol2008，26，4：	1
20	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD	2002	N EnglJ Med2002，347，7：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示